Published online before print November 7, 2002, doi: 10.1161/01.RES.0000046236.20251.FA
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 11, 2002
Revised on October 28, 2002
Accepted on October 28, 2002
Apoptosis and Cellular Activation in the Pathogenesis of Acute Vascular Rejection
Zoie E. Holzknecht ;
From the Departments of Surgery (Z.E.H., K.L.K., T.B.P., J.W., J.L.P.), Gastroenterology (G.J.G.), Pediatrics (J.L.P.), and Immunology (J.L.P.), Mayo Clinic, Rochester, Minn, and the Division of Hepatology and Gene Therapy (M.B., G.J.B.), Universidad de Navarra, Pamplona, Spain.
* To whom correspondence should be addressed. E-mail: platt.jeffrey{at}mayo.edu.
Acute vascular or humoral rejection, a vexing outcome of organ transplantation, has been attributed by some to activation and by others to apoptosis of endothelial cells in the graft. We asked which of these processes causes acute vascular rejection by tracing the processes during the development of acute vascular rejection in porcine cardiac xenografts performed in baboons. Apoptosis, assayed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) expression of activated caspase-3 and proapoptotic genes Bax and Bcl-xL, was not detected until acute vascular rejection was well advanced, and even then, apoptosis was largely confined to myocytes. Activation of the endothelium, as evidenced by expansion of rough endoplasmic reticulum and increased ribosomal antigen and phospho-p70 S6 kinase, occurred early in the course of acute vascular rejection and progressed through the disease process. These findings suggest that acute vascular rejection is caused by an active metabolic process and not by apoptosis in the endothelium.
Key words: apoptosis • endothelial cells • xenotransplantation • cardiac transplantation
This article has been cited by other articles:
 |
|
 |
|
  A. Shimizu, Y. Hisashi, K. Kuwaki, Y.-L. Tseng, F. J.M.F. Dor, S. L. Houser, S. C. Robson, H.-J. Schuurman, D. K.C. Cooper, D. H. Sachs, et al. Thrombotic Microangiopathy Associated with Humoral Rejection of Cardiac Xenografts from {alpha}1,3-Galactosyltransferase Gene-Knockout Pigs in Baboons Am. J. Pathol., June 1, 2008; 172(6): 1471 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Jindra, A. Hsueh, L. Hong, D. Gjertson, X.-D. Shen, F. Gao, J. Dang, P. S. Mischel, W. M. Baldwin III, M. C. Fishbein, et al. Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts J. Immunol., February 15, 2008; 180(4): 2214 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shimizu, K. Yamada, S. Yamamoto, J. M. Lavelle, R. N. Barth, S. C. Robson, D. H. Sachs, and R. B. Colvin Thrombotic Microangiopathic Glomerulopathy in Human Decay Accelerating Factor-Transgenic Swine-to-Baboon Kidney Xenografts J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2732 - 2745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cascalho, B. M. Ogle, and J. L. Platt Xenotransplantation and the Future of Renal Replacement J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1106 - 1112. [Full Text] [PDF]
|
|
|
|
|
|
A. Ghanekar, M. Mendicino, H. Liu, W. He, M. Liu, R. Zhong, M. J. Phillips, G. A. Levy, and D. R. Grant Endothelial Induction of fgl2 Contributes to Thrombosis during Acute Vascular Xenograft Rejection J. Immunol., May 1, 2004; 172(9): 5693 - 5701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Mazer and D. J. Pinsky Alive and Kicking: Endothelium at the Geographic Nexus of Vascular Rejection Circ. Res., December 13, 2002; 91(12): 1085 - 1088. [Full Text] [PDF]
|
|